ID   CLK1_HUMAN              Reviewed;         484 AA.
AC   P49759; B4DFW7; Q0P694; Q8N5V8;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Dual specificity protein kinase CLK1;
DE            EC=2.7.12.1;
DE   AltName: Full=CDC-like kinase 1;
GN   Name=CLK1; Synonyms=CLK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1704889;
RA   Johnson K.W., Smith K.A.;
RT   "Molecular cloning of a novel human cdc2/CDC28-like protein kinase.";
RL   J. Biol. Chem. 266:3402-3407(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=7990150; DOI=10.1006/jmbi.1994.1763;
RA   Hanes J.J., der Kammer H., Klaudiny J.J., Scheit K.H.;
RT   "Characterization by cDNA cloning of two new human protein kinases.
RT   Evidence by sequence comparison of a new family of mammalian protein
RT   kinases.";
RL   J. Mol. Biol. 244:665-672(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Blood, and Bone;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=10480872; DOI=10.1074/jbc.274.38.26697;
RA   Moeslein F.M., Myers M.P., Landreth G.E.;
RT   "The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the
RT   tyrosine phosphatase, PTP-1B.";
RL   J. Biol. Chem. 274:26697-26704(1999).
RN   [8]
RP   INTERACTION WITH UBL5.
RX   PubMed=12705895; DOI=10.1016/S0006-291X(03)00549-7;
RA   Kantham L., Kerr-Bayles L., Godde N., Quick M., Webb R.,
RA   Sunderland T., Bond J., Walder K., Augert G., Collier G.;
RT   "Beacon interacts with cdc2/cdc28-like kinases.";
RL   Biochem. Biophys. Res. Commun. 304:125-129(2003).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-61 AND SER-140, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-138 AND SER-140, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=19168442; DOI=10.1161/CIRCRESAHA.108.183905;
RA   Eisenreich A., Bogdanov V.Y., Zakrzewicz A., Pries A., Antoniak S.,
RA   Poller W., Schultheiss H.P., Rauch U.;
RT   "Cdc2-like kinases and DNA topoisomerase I regulate alternative
RT   splicing of tissue factor in human endothelial cells.";
RL   Circ. Res. 104:589-599(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-61; GLY-118; SER-307 AND THR-440.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Dual specificity kinase acting on both serine/threonine
CC       and tyrosine-containing substrates. Phosphorylates serine- and
CC       arginine-rich (SR) proteins of the spliceosomal complex and may be
CC       a constituent of a network of regulatory mechanisms that enable SR
CC       proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and
CC       PTPN1. Regulates the alternative splicing of tissue factor (F3)
CC       pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA.
CC       {ECO:0000269|PubMed:10480872, ECO:0000269|PubMed:19168442}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Regulates splicing of its own pre-mRNA
CC       according to its kinase activity; increased expression of the
CC       catalytically active form influences splicing to generate the
CC       catalytically inactive splicing variant lacking the kinase domain.
CC       Leucettine L41 inhibits its kinase activity and affects the
CC       regulation of alternative splicing mediated by phosphorylation of
CC       SR proteins (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PPIG and UBL5.
CC       {ECO:0000269|PubMed:12705895}.
CC   -!- INTERACTION:
CC       P49760:CLK2; NbExp=4; IntAct=EBI-11981867, EBI-750020;
CC       P60409:KRTAP10-7; NbExp=3; IntAct=EBI-473775, EBI-10172290;
CC       O76083:PDE9A; NbExp=3; IntAct=EBI-473775, EBI-742764;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long;
CC         IsoId=P49759-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P49759-2; Sequence=VSP_004852, VSP_004853;
CC         Note=Lacks the kinase domain. May be produced at very low levels
CC         due to a premature stop codon in the mRNA, leading to
CC         nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=P49759-3; Sequence=VSP_043578;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Endothelial cells.
CC       {ECO:0000269|PubMed:19168442}.
CC   -!- PTM: Autophosphorylates on all three types of residues.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. Lammer subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L29219; AAA61480.1; -; mRNA.
DR   EMBL; L29222; AAB59459.1; -; mRNA.
DR   EMBL; AK289365; BAF82054.1; -; mRNA.
DR   EMBL; AK294295; BAG57578.1; -; mRNA.
DR   EMBL; AC005037; AAY14722.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70217.1; -; Genomic_DNA.
DR   EMBL; BC028149; AAH28149.1; -; mRNA.
DR   EMBL; BC031549; AAH31549.1; -; mRNA.
DR   CCDS; CCDS2331.1; -. [P49759-1]
DR   CCDS; CCDS54427.1; -. [P49759-3]
DR   PIR; S53641; S53641.
DR   RefSeq; NP_001155879.1; NM_001162407.1. [P49759-3]
DR   RefSeq; NP_004062.2; NM_004071.3. [P49759-1]
DR   UniGene; Hs.433732; -.
DR   PDB; 1Z57; X-ray; 1.70 A; A=148-484.
DR   PDB; 2VAG; X-ray; 1.80 A; A=148-484.
DR   PDB; 5J1V; X-ray; 2.52 A; A/B/C=148-484.
DR   PDB; 5J1W; X-ray; 2.42 A; A/B/C=148-484.
DR   PDBsum; 1Z57; -.
DR   PDBsum; 2VAG; -.
DR   PDBsum; 5J1V; -.
DR   PDBsum; 5J1W; -.
DR   ProteinModelPortal; P49759; -.
DR   SMR; P49759; -.
DR   BioGrid; 107606; 167.
DR   IntAct; P49759; 31.
DR   MINT; MINT-8417657; -.
DR   STRING; 9606.ENSP00000394734; -.
DR   BindingDB; P49759; -.
DR   ChEMBL; CHEMBL4224; -.
DR   DrugBank; DB04367; Debromohymenialdisine.
DR   GuidetoPHARMACOLOGY; 1990; -.
DR   iPTMnet; P49759; -.
DR   PhosphoSitePlus; P49759; -.
DR   BioMuta; CLK1; -.
DR   DMDM; 206729857; -.
DR   EPD; P49759; -.
DR   MaxQB; P49759; -.
DR   PaxDb; P49759; -.
DR   PeptideAtlas; P49759; -.
DR   PRIDE; P49759; -.
DR   DNASU; 1195; -.
DR   Ensembl; ENST00000321356; ENSP00000326830; ENSG00000013441. [P49759-1]
DR   Ensembl; ENST00000432425; ENSP00000400487; ENSG00000013441. [P49759-2]
DR   Ensembl; ENST00000434813; ENSP00000394734; ENSG00000013441. [P49759-3]
DR   GeneID; 1195; -.
DR   KEGG; hsa:1195; -.
DR   UCSC; uc002uwe.3; human. [P49759-1]
DR   CTD; 1195; -.
DR   DisGeNET; 1195; -.
DR   GeneCards; CLK1; -.
DR   HGNC; HGNC:2068; CLK1.
DR   HPA; CAB033141; -.
DR   HPA; HPA062405; -.
DR   MalaCards; CLK1; -.
DR   MIM; 601951; gene.
DR   neXtProt; NX_P49759; -.
DR   OpenTargets; ENSG00000013441; -.
DR   PharmGKB; PA26594; -.
DR   eggNOG; KOG0671; Eukaryota.
DR   eggNOG; ENOG410XQF2; LUCA.
DR   GeneTree; ENSGT00580000081366; -.
DR   HOGENOM; HOG000203417; -.
DR   HOVERGEN; HBG107720; -.
DR   InParanoid; P49759; -.
DR   KO; K08823; -.
DR   OMA; YVEEYNP; -.
DR   OrthoDB; EOG091G033A; -.
DR   PhylomeDB; P49759; -.
DR   TreeFam; TF101041; -.
DR   BRENDA; 2.7.12.1; 2681.
DR   SignaLink; P49759; -.
DR   SIGNOR; P49759; -.
DR   ChiTaRS; CLK1; human.
DR   EvolutionaryTrace; P49759; -.
DR   GeneWiki; CLK1; -.
DR   GenomeRNAi; 1195; -.
DR   PRO; PR:P49759; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000013441; -.
DR   CleanEx; HS_CLK1; -.
DR   ExpressionAtlas; P49759; baseline and differential.
DR   Genevisible; P49759; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0043484; P:regulation of RNA splicing; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN         1    484       Dual specificity protein kinase CLK1.
FT                                /FTId=PRO_0000085866.
FT   DOMAIN      161    477       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     167    175       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    288    288       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     191    191       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      61     61       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976}.
FT   MOD_RES     138    138       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     140    140       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1      1       M -> MAAGRRPASALWPERRGSPLRGDLLGFQNVREPSSC
FT                                GETLSGM (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043578.
FT   VAR_SEQ     131    136       KSHRRK -> MKLLIL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7990150}.
FT                                /FTId=VSP_004852.
FT   VAR_SEQ     137    484       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7990150}.
FT                                /FTId=VSP_004853.
FT   VARIANT      61     61       S -> F (in dbSNP:rs55989135).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040409.
FT   VARIANT      99     99       N -> D (in dbSNP:rs6735666).
FT                                /FTId=VAR_046551.
FT   VARIANT     118    118       R -> G (in dbSNP:rs56135616).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040410.
FT   VARIANT     307    307       P -> S (in dbSNP:rs35412475).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040411.
FT   VARIANT     440    440       M -> T (in dbSNP:rs35393352).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040412.
FT   VARIANT     459    459       E -> G (in dbSNP:rs12709).
FT                                /FTId=VAR_051620.
FT   CONFLICT    432    432       R -> A (in Ref. 1; AAA61480).
FT                                {ECO:0000305}.
FT   HELIX       148    150       {ECO:0000244|PDB:2VAG}.
FT   TURN        158    160       {ECO:0000244|PDB:1Z57}.
FT   STRAND      161    170       {ECO:0000244|PDB:1Z57}.
FT   STRAND      173    180       {ECO:0000244|PDB:1Z57}.
FT   TURN        181    185       {ECO:0000244|PDB:1Z57}.
FT   STRAND      187    193       {ECO:0000244|PDB:1Z57}.
FT   HELIX       197    216       {ECO:0000244|PDB:1Z57}.
FT   STRAND      227    233       {ECO:0000244|PDB:1Z57}.
FT   STRAND      236    242       {ECO:0000244|PDB:1Z57}.
FT   HELIX       248    254       {ECO:0000244|PDB:1Z57}.
FT   TURN        255    257       {ECO:0000244|PDB:1Z57}.
FT   HELIX       262    281       {ECO:0000244|PDB:1Z57}.
FT   HELIX       291    293       {ECO:0000244|PDB:1Z57}.
FT   STRAND      294    297       {ECO:0000244|PDB:1Z57}.
FT   STRAND      301    305       {ECO:0000244|PDB:1Z57}.
FT   TURN        307    310       {ECO:0000244|PDB:5J1W}.
FT   STRAND      312    317       {ECO:0000244|PDB:1Z57}.
FT   STRAND      321    323       {ECO:0000244|PDB:1Z57}.
FT   HELIX       343    345       {ECO:0000244|PDB:1Z57}.
FT   HELIX       348    351       {ECO:0000244|PDB:1Z57}.
FT   HELIX       359    374       {ECO:0000244|PDB:1Z57}.
FT   HELIX       384    395       {ECO:0000244|PDB:1Z57}.
FT   HELIX       400    405       {ECO:0000244|PDB:1Z57}.
FT   HELIX       409    411       {ECO:0000244|PDB:1Z57}.
FT   HELIX       424    432       {ECO:0000244|PDB:1Z57}.
FT   HELIX       436    439       {ECO:0000244|PDB:1Z57}.
FT   HELIX       445    457       {ECO:0000244|PDB:1Z57}.
FT   TURN        462    464       {ECO:0000244|PDB:1Z57}.
FT   HELIX       468    471       {ECO:0000244|PDB:1Z57}.
FT   HELIX       475    481       {ECO:0000244|PDB:1Z57}.
SQ   SEQUENCE   484 AA;  57291 MW;  F34B5B44988BD118 CRC64;
     MRHSKRTYCP DWDDKDWDYG KWRSSSSHKR RKRSHSSAQE NKRCKYNHSK MCDSHYLESR
     SINEKDYHSR RYIDEYRNDY TQGCEPGHRQ RDHESRYQNH SSKSSGRSGR SSYKSKHRIH
     HSTSHRRSHG KSHRRKRTRS VEDDEEGHLI CQSGDVLSAR YEIVDTLGEG AFGKVVECID
     HKAGGRHVAV KIVKNVDRYC EAARSEIQVL EHLNTTDPNS TFRCVQMLEW FEHHGHICIV
     FELLGLSTYD FIKENGFLPF RLDHIRKMAY QICKSVNFLH SNKLTHTDLK PENILFVQSD
     YTEAYNPKIK RDERTLINPD IKVVDFGSAT YDDEHHSTLV STRHYRAPEV ILALGWSQPC
     DVWSIGCILI EYYLGFTVFP THDSKEHLAM MERILGPLPK HMIQKTRKRK YFHHDRLDWD
     EHSSAGRYVS RRCKPLKEFM LSQDVEHERL FDLIQKMLEY DPAKRITLRE ALKHPFFDLL
     KKSI
//
